Apararenone
id:
apararenone-180-17779897
title:
Apararenone
text:
Apararenone (INN) is a nonsteroidal antimineralocorticoid which is under development by Mitsubishi Tanabe Pharma for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis. It was also previously being developed for the treatment of hypertension, but development was discontinued for this indication. Apararenone acts as a highly selective antagonist of the mineralocorticoid receptor, the receptor for aldosterone. As of 2017, it is in phase II clinical trials.
brand slug:
wiki
category slug:
encyclopedia
description:
Nonsteroidal antimineralocorticoid
original url:
https://en.wikipedia.org/wiki/Apararenone
date created:
2017-05-31T23:48:37Z
date modified:
2024-09-05T13:52:47Z
main entity:
{"identifier":"Q30315100","url":"https://www.wikidata.org/entity/Q30315100"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b5/Apararenone.svg","width":550,"height":540}
fields total:
13
integrity:
16